Workup and Management of Low Serum Ferritin
Begin oral iron supplementation immediately with ferrous sulfate 65 mg elemental iron daily (or alternate-day dosing) while simultaneously investigating the underlying cause—do not delay treatment pending diagnostic workup. 1
Diagnostic Interpretation
Ferritin Thresholds for Iron Deficiency
- Ferritin <15 μg/L has 99% specificity for absolute iron deficiency, providing definitive confirmation without need for additional testing 1
- Ferritin 15-30 μg/L indicates depleted iron stores and warrants treatment 1
- Ferritin <45 μg/L provides optimal sensitivity-specificity balance (92% specificity) for clinical decision-making 1
Critical Caveat: Rule Out Inflammation
Ferritin is an acute-phase reactant that rises during inflammation, infection, or tissue damage, potentially masking true iron deficiency. 1 In patients with chronic inflammatory conditions (inflammatory bowel disease, chronic kidney disease, heart failure, cancer), the diagnostic threshold shifts upward to ferritin <100 μg/L. 1
Always calculate transferrin saturation (TSAT): Values <16-20% confirm iron deficiency even when ferritin appears normal or elevated due to inflammation. 1 The formula is: (serum iron × 100) ÷ total iron-binding capacity. 1
Mandatory Workup to Identify the Source
For All Adults
- Screen for celiac disease with tissue transglutaminase IgA antibodies—celiac disease accounts for 3-5% of iron deficiency cases and causes treatment failure if missed 1
- Test for Helicobacter pylori non-invasively (stool antigen or urea breath test) as it impairs iron absorption 1
For Adult Men and Postmenopausal Women
Urgent bidirectional endoscopy (upper GI gastroscopy + colonoscopy) is mandatory because iron deficiency may be the sole manifestation of gastrointestinal malignancy. 1
For Premenopausal Women
GI investigation is conditional rather than mandatory unless specific red flags are present. 1 First assess menstrual blood loss history, as heavy menses are the most common cause in this population. 1
Reserve bidirectional endoscopy for:
- Age ≥50 years (higher malignancy risk) 1
- GI symptoms (abdominal pain, altered bowel habits, visible blood) 1
- Positive celiac or H. pylori testing requiring confirmation 1
- Failure to respond to adequate oral iron after 8-10 weeks 1
- Strong family history of colorectal cancer 1
Treatment Protocol
First-Line: Oral Iron Supplementation
Start ferrous sulfate 65 mg elemental iron daily (equivalent to 325 mg ferrous sulfate tablet). 1 Alternatively, 60-65 mg every other day improves absorption by 30-50% and reduces GI side effects. 1
- Take on empty stomach for optimal absorption, or with meals if GI symptoms occur 1
- Expected side effects: constipation, nausea, diarrhea—can be minimized by taking with food or switching to alternate-day dosing 1
- Expected response: hemoglobin should rise ≥10 g/L within 2 weeks 1
Continue oral iron for 3 months after hemoglobin normalizes to achieve target ferritin >100 ng/mL and prevent rapid recurrence. 1 Standard-dose oral iron does not cause ferritin to rise until hemoglobin levels normalize. 2
When to Switch to Intravenous Iron
Use IV ferric carboxymaltose (15 mg/kg, maximum 1000 mg per dose) when any of the following apply: 1
- Oral iron intolerance (marked nausea, constipation, diarrhea)
- Confirmed malabsorption (celiac disease, inflammatory bowel disease, post-bariatric surgery)
- Ongoing blood loss exceeding oral replacement capacity
- Chronic inflammatory conditions (CKD, heart failure, IBD, cancer)
- Pregnancy in second/third trimester
IV iron produces reticulocytosis within 3-5 days and yields mean hemoglobin increase of ≈8 g/L over 8 days, demonstrating superior efficacy in these populations. 1
Follow-Up and Monitoring
- Repeat CBC and ferritin at 8-10 weeks to assess response to treatment 1
- Target ferritin >100 ng/mL to restore iron stores and prevent recurrence 1
- If no improvement occurs, consider malabsorption, non-compliance, ongoing blood loss, or need for IV iron 1
For high-risk groups (menstruating females, vegetarians, athletes, regular blood donors), screen ferritin every 6-12 months to detect early depletion before anemia develops. 1
Common Pitfalls to Avoid
- Do not assume normal ferritin excludes iron deficiency—transferrin saturation is the key parameter for assessing iron availability when inflammation is present 1
- Do not overlook celiac disease screening—its 3-5% prevalence in iron deficiency cases leads to treatment failure if missed 1
- Do not discontinue iron therapy once hemoglobin normalizes—an additional 3 months of supplementation is required for ferritin to reach >100 ng/mL 1
- Do not delay endoscopic evaluation in high-risk patients (age ≥50, alarm symptoms, treatment failure), as GI malignancy can present solely with iron deficiency 1
- In patients with normocytic anemia and ferritin >50 μg/L, do not automatically assume adequate iron stores—consider checking soluble transferrin receptor or sTfR-ferritin index to exclude functional iron deficiency 3